Edges in Network
Network | GSE18864_egf1520 - GSE18864 - SiGN-BN HC+Bootstrap |
Network Description | Tumor expression data from neoadjuvant trial of cisplatin monotherapy in triple negative breast cancer patients |
Node | CEP170 |
Upstream (Parents) |
---|
(<<) CBL → CEP170 |
(<<) CCDC88A → CEP170 |
(<<) CENPF → CEP170 |
(<<) CRKL → CEP170 |
(<<) CTSF → CEP170 |
(<<) DUSP7 → CEP170 |
(<<) LCE3D → CEP170 |
(<<) LRP6 → CEP170 |
(<<) MAPK14 → CEP170 |
(<<) MMP9 → CEP170 |
(<<) MSN → CEP170 |
(<<) PPP1R15B → CEP170 |
(<<) PRKCA → CEP170 |
(<<) RNF138 → CEP170 |
(<<) RRP15 → CEP170 |
(<<) SESN1 → CEP170 |
(<<) SPAG5 → CEP170 |
(<<) SPR → CEP170 |
(<<) SULT1A2 → CEP170 |
(<<) TPSG1 → CEP170 |
(<<) UBE2E3 → CEP170 |
(<<) UBQLN2 → CEP170 |
Downstream (Children) |
---|
CEP170 → APH1B (>>) |
CEP170 → CASKIN1 (>>) |
CEP170 → DDX21 (>>) |
CEP170 → E2F3 (>>) |
CEP170 → EGF (>>) |
CEP170 → FUT4 (>>) |
CEP170 → FZD7 (>>) |
CEP170 → GNAI1 (>>) |
CEP170 → ILDR1 (>>) |
CEP170 → KCTD5 (>>) |
CEP170 → NOL9 (>>) |
CEP170 → NUPR1 (>>) |
CEP170 → PRKCI (>>) |
CEP170 → PRPF4B (>>) |
CEP170 → PYGL (>>) |
CEP170 → SMARCC2 (>>) |
CEP170 → TEX10 (>>) |